Biography
Shreya Badhrinarayanan, MD, FRSPH is the Global Development Lead for Clinical Development Oncology Hematology at Pfizer. In this role, she leads advancements in ADCs and IO biologics within hematology and oncology.Previously at Genentech, a Roche subsidiary, she provided strategic direction for the development of new Immuno-Oncology drugs by leading cross-functional teams and conducting medical monitoring of clinical trials. Earlier in her career, she served as a Physician with the National Health Service (NHS) in the UK, where she made significant contributions to clinical and research initiatives.Thriving in the field of medical leadership and management, Dr. Badhrinarayanan received the Edward Jenner Award from the NHS Leadership Academy. To further her passion for teaching, she served as an Honorary Lecturer in Medical Education and Simulation at the University of Adelaide Medical School, Australia. Her wide range of interests varies from AI in health care to DI initiatives that have been embodied through her contributions to print and media as well as at conferences across the globe. In addition, she is the editorreviewer of numerous high-impact journals, including the British Medical Journal.For her work and commitment towards public health, Dr. Badhrinarayanan was elected as a Fellow of the Royal Society of Public Health, UK. She received her medical degree from Brighton and Sussex Medical School, UK, with numerous accolades.